Real-time enrollment status for this acute myeloid leukemias clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:02 PM UTC
| NCT Number | NCT07211958 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemias |
| Phase | PHASE3 |
| Target Enrollment | 468 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Syndax Pharmaceuticals |
| Last Updated on CT.gov | August 28, 2026 (5 days ago) |
As of September 2, 2026: Clinical trial NCT07211958 is currently recruiting participants. This phase3 study for acute myeloid leukemias is actively seeking new participants at 3 locations across the United States. The study is sponsored by Syndax Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07211958 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07211958 was last updated 5 days ago (August 28, 2026). HelloStudys verifies this status automatically.